{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:33:28Z","timestamp":1791812008968,"version":"4.3.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2021R1A6C101A442"],"award-info":[{"award-number":["2021R1A6C101A442"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2024\\u201300431505"],"award-info":[{"award-number":["RS-2024\\u201300431505"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["NRF- RS-2024\\u201300345936"],"award-info":[{"award-number":["NRF- RS-2024\\u201300345936"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["NRF-2022R1A2C2092053"],"award-info":[{"award-number":["NRF-2022R1A2C2092053"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003716","name":"Korea Basic Science Institute","doi-asserted-by":"publisher","award":["C523400"],"award-info":[{"award-number":["C523400"]}],"id":[{"id":"10.13039\/501100003716","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003716","name":"Korea Basic Science Institute","doi-asserted-by":"publisher","award":["C523100"],"award-info":[{"award-number":["C523100"]}],"id":[{"id":"10.13039\/501100003716","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001381","name":"National Research Foundation Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118798","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:16:37Z","timestamp":1763763397000},"page":"118798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["KN21, a direct AMPK activator, alleviates hepatic steatosis and fibrosis by modulating long-chain TAG and pyrimidine metabolism in a MASH mouse model"],"prefix":"10.1016","volume":"193","author":[{"given":"Jueun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seojeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeajin","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjung","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeri","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2070-7604","authenticated-orcid":false,"given":"Jae-Ho","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younghwa","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6256-3042","authenticated-orcid":false,"given":"Youngjoo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1600-1556","authenticated-orcid":false,"given":"Geum-Sook","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10290","key":"10.1016\/j.biopha.2025.118798_bib1","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.118798_bib2","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.2147\/DDDT.S315724","article-title":"development, therapy, Non-alcoholic steatohepatitis (NASH)\u2013A review of a crowded clinical landscape, driven by a complex disease","author":"Fraile","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"issue":"8","key":"10.1016\/j.biopha.2025.118798_bib3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","article-title":"Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus","volume":"17","author":"Ferguson","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.biopha.2025.118798_bib4","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2741\/4892","article-title":"Current treatment paradigms and emerging therapies for NAFLD\/NASH","volume":"26","author":"Raza","year":"2021","journal-title":"Front. Biosci."},{"issue":"04","key":"10.1016\/j.biopha.2025.118798_bib5","first-page":"508","article-title":"Nonalcoholic steatohepatitis (NASH)\u2013current treatment recommendations and future developments","volume":"57","author":"Roeb","year":"2019","journal-title":"Gastroenterologie"},{"issue":"6","key":"10.1016\/j.biopha.2025.118798_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41575-020-00408-y","article-title":"Hepatology, therapeutic pipeline in nonalcoholic steatohepatitis","volume":"18","author":"Vuppalanchi","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118798_bib7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s40265-024-02045-0","article-title":"Resmetirom: first approval","volume":"84","author":"Keam","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2025.118798_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ceb.2017.01.005","article-title":"AMPK signalling in health and disease","volume":"45","author":"Carling","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118798_bib9","article-title":"AMPK against NASH","volume":"21","author":"P.J.N.R.M.C.B. Strzyz","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118798_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4062\/biomolther.2024.188","article-title":"Therapeutics, new insights into AMPK, as a potential therapeutic target in metabolic dysfunction-associated steatotic liver disease and hepatic fibrosis","volume":"33","author":"An","year":"2024","journal-title":"Biomol. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2025.118798_bib11","doi-asserted-by":"crossref","first-page":"E730","DOI":"10.1152\/ajpendo.00225.2016","article-title":"Treatment of nonalcoholic fatty liver disease: role of AMPK","volume":"311","author":"Smith","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"17","key":"10.1016\/j.biopha.2025.118798_bib12","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1111\/bph.14434","article-title":"Metabolomic and lipidomic analysis of the effect of pioglitazone on hepatic steatosis in a rat model of obese type 2 diabetes","volume":"175","author":"Yang","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118798_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152936","article-title":"Lipidomic analysis reveals therapeutic effects of Yijin-Tang on high-fat\/high-cholesterol diet-induced obese mice","volume":"74","author":"Lee","year":"2020","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.biopha.2025.118798_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/mol.113.089755","article-title":"Valproic acid is a novel activator of AMP-activated protein kinase and decreases liver mass, hepatic fat accumulation, and serum glucose in obese mice","volume":"85","author":"Avery","year":"2014","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118798_bib15","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1021\/acsnano.3c06107","article-title":"Antioxidative hyaluronic acid\u2013bilirubin nanomedicine targeting activated hepatic stellate cells for anti-hepatic-fibrosis therapy","volume":"18","author":"Shinn","year":"2024","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.biopha.2025.118798_bib16","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.7150\/ijbs.92371","article-title":"A novel A2a adenosine receptor inhibitor effectively mitigates hepatic fibrosis in a metabolic dysfunction-associated steatohepatitis mouse model","volume":"20","author":"Park","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2025.118798_bib17","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.7150\/ijbs.108731","article-title":"Pharmacological activation of AMP-activated protein kinase ameliorates liver fibrosis in a metabolic dysfunction-associated steatohepatitis mouse model","volume":"21","author":"Kim","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2025.118798_bib18","doi-asserted-by":"crossref","first-page":"1473895","DOI":"10.3389\/fimmu.2024.1473895","article-title":"Unraveling metabolic signatures in SARS-CoV-2 variant infections using multiomics analysis","volume":"15","author":"Lee","year":"2024","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118798_bib19","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bbadis.2011.02.014","article-title":"PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation","volume":"1812","author":"Varga","year":"2011","journal-title":"Biochim. Et. Biophys. Acta (BBA) Mol. Basis Dis."},{"issue":"4","key":"10.1016\/j.biopha.2025.118798_bib20","doi-asserted-by":"crossref","first-page":"G527","DOI":"10.1152\/ajpgi.00148.2018","article-title":"Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing \u03b2-oxidation of fatty acid in mice","volume":"316","author":"Yao","year":"2019","journal-title":"Gastrointest. Liver Physiol."},{"issue":"34","key":"10.1016\/j.biopha.2025.118798_bib21","doi-asserted-by":"crossref","first-page":"12279","DOI":"10.1074\/jbc.REV120.011356","article-title":"From overnutrition to liver injury: AMP-activated protein kinase in nonalcoholic fatty liver diseases","volume":"295","author":"Zhao","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"6478","key":"10.1016\/j.biopha.2025.118798_bib22","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1126\/science.aay0542","article-title":"An AMPK\u2013caspase-6 axis controls liver damage in nonalcoholic steatohepatitis","volume":"367","author":"Zhao","year":"2020","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.biopha.2025.118798_bib23","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1038\/ijo.2008.116","article-title":"AMPK: a key regulator of energy balance in the single cell and the whole organism","volume":"32","author":"Hardie","year":"2008","journal-title":"Int. J. Obes."},{"issue":"8","key":"10.1016\/j.biopha.2025.118798_bib24","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1161\/01.RES.0000163633.10240.3b","article-title":"AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle","volume":"96","author":"Ouchi","year":"2005","journal-title":"Circ. Res."},{"issue":"18","key":"10.1016\/j.biopha.2025.118798_bib25","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118798_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/srep46658","article-title":"Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients","volume":"7","author":"Chiappini","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2025.118798_bib27","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1039\/C4AN01679C","article-title":"Vibrational signatures to discriminate liver steatosis grades","volume":"140","author":"Peng","year":"2015","journal-title":"Analyst"},{"key":"10.1016\/j.biopha.2025.118798_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.10.046","article-title":"Lipidomic profiling identifies signatures of metabolic risk","volume":"51","author":"Yin","year":"2020","journal-title":"eBioMedicine"},{"issue":"1","key":"10.1016\/j.biopha.2025.118798_bib29","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3390\/ijms13010994","article-title":"Boesenbergia pandurata attenuates diet-induced obesity by activating AMP-activated protein kinase and regulating lipid metabolism","volume":"13","author":"Kim","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.biopha.2025.118798_bib30","doi-asserted-by":"crossref","first-page":"13108","DOI":"10.1074\/jbc.M708086200","article-title":"CD36 mediates both cellular uptake of very long chain fatty acids and their intestinal absorption in mice","volume":"283","author":"Drover","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.biopha.2025.118798_bib31","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","article-title":"Disease, understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?","volume":"11","author":"Rada","year":"2020","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.biopha.2025.118798_bib32","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/en.2015-1866","article-title":"Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice","volume":"157","author":"Wilson","year":"2016","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.biopha.2025.118798_bib33","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.biochi.2004.09.018","article-title":"SREBP transcription factors: master regulators of lipid homeostasis","volume":"86","author":"Eberl\u00e9","year":"2004","journal-title":"Biochimie"},{"key":"10.1016\/j.biopha.2025.118798_bib34","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/embo-reports\/kve071","article-title":"Mechanisms of nutritional and hormonal regulation of lipogenesis","volume":"2","author":"Kersten","year":"2001","journal-title":"EMBO Rep."},{"key":"10.1016\/j.biopha.2025.118798_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101428","article-title":"CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing","volume":"57","author":"Zeng","year":"2022","journal-title":"Mol. Metab."},{"issue":"6","key":"10.1016\/j.biopha.2025.118798_bib36","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1478-3231.2010.02248.x","article-title":"Apoptosis is associated with CD36\/fatty acid translocase upregulation in non-alcoholic steatohepatitis","volume":"30","author":"Bechmann","year":"2010","journal-title":"Liver Intern."},{"issue":"24","key":"10.1016\/j.biopha.2025.118798_bib37","doi-asserted-by":"crossref","first-page":"7669","DOI":"10.1021\/bi060198l","article-title":"Very-long-chain and branched-chain fatty acyl-CoAs are high affinity ligands for the peroxisome proliferator-activated receptor alpha (PPARalpha)","volume":"45","author":"Hostetler","year":"2006","journal-title":"Biochemistry"},{"issue":"3738","key":"10.1016\/j.biopha.2025.118798_bib38","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2010.13071","article-title":"Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels","volume":"140","author":"Yessoufou","year":"2010","journal-title":"Swiss Med. Wkly."},{"issue":"7","key":"10.1016\/j.biopha.2025.118798_bib39","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1210\/me.2002-0190","volume":"17","author":"Yoshikawa","year":"2003","journal-title":"Mol. Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118798_bib40","article-title":"Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases","volume":"2013","author":"Monsalve","year":"2013","journal-title":"Mediat. Inflamm."},{"issue":"5","key":"10.1016\/j.biopha.2025.118798_bib41","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/bcpt.13190","article-title":"A role of peroxisome proliferator-activated receptor \u03b3 in non-alcoholic fatty liver disease","volume":"124","author":"Skat-R\u00f8rdam","year":"2019","journal-title":"Basic Clin. Pharm. Toxicol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118798_bib42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best. Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.biopha.2025.118798_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","author":"Horn","year":"2024","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.biopha.2025.118798_bib44","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2020.04.037","article-title":"Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation","volume":"73","author":"Bates","year":"2020","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118798_bib45","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jcmgh.2020.06.001","article-title":"Hepatology, acetyl-CoA carboxylase inhibition improves multiple dimensions of NASH pathogenesis in model systems","volume":"10","author":"Ross","year":"2020","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118798_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abq2937","article-title":"The role of altered lipid composition and distribution in liver fibrosis revealed by multimodal nonlinear optical microscopy","volume":"9","author":"Jia","year":"2023","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.biopha.2025.118798_bib47","article-title":"Uridine metabolism and its role in glucose, lipid, and amino acid homeostasis","volume":"2020","author":"Zhang","year":"2020","journal-title":"BioMed. Res. Int."},{"issue":"22","key":"10.1016\/j.biopha.2025.118798_bib48","doi-asserted-by":"crossref","first-page":"21169","DOI":"10.1074\/jbc.M412343200","article-title":"Abnormalities in uridine homeostatic regulation and pyrimidine nucleotide metabolism as a consequence of the deletion of the uridine phosphorylase gene","volume":"280","author":"Cao","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2025.118798_bib49","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1194\/jlr.M034249","article-title":"Disruption of uridine homeostasis links liver pyrimidine metabolism to lipid accumulation","volume":"54","author":"Le","year":"2013","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118798_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17860-2","article-title":"Uncovering the roles of dihydropyrimidine dehydrogenase in fatty-acid induced steatosis using human cellular models","volume":"12","author":"Sullivan","year":"2022","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2025.118798_bib51","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1039\/D0FO02533J","article-title":"Function, Uridine attenuates obesity, ameliorates hepatic lipid accumulation and modifies the gut microbiota composition in mice fed with a high-fat diet","volume":"12","author":"Liu","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.biopha.2025.118798_bib52","article-title":"Therapeutic effect of uridine phosphorylase 1 (UPP1) inhibitor on liver fibrosis in vitro and in vivo","volume":"890","author":"da Silva","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118798_bib53","doi-asserted-by":"crossref","unstructured":"W.V. Zheng, Y. Li, X. Cheng, Y. Xu, T. Zhou, D. Li, Y. Xiong, S. Wang, Z.J.Jo.C. Chen, M. Medicine, Uridine alleviates carbon tetrachloride-induced liver fibrosis by regulating the activity of liver-related cells, 26(3) (2022) 840\u2013854.","DOI":"10.1111\/jcmm.17131"},{"issue":"11","key":"10.1016\/j.biopha.2025.118798_bib54","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.molcel.2024.04.026","article-title":"mTORC1-CTLH E3 ligase regulates the degradation of HMG-CoA synthase 1 through the Pro\/N-degron pathway","volume":"84","author":"Yi","year":"2024","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.biopha.2025.118798_bib55","article-title":"Uridine metabolism and its role in glucose, lipid, and amino acid homeostasis","volume":"2020","author":"Zhang","year":"2020","journal-title":"BioMed. Res. Int."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:00:25Z","timestamp":1778504425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225009928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":55,"alternative-id":["S0753332225009928"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118798","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KN21, a direct AMPK activator, alleviates hepatic steatosis and fibrosis by modulating long-chain TAG and pyrimidine metabolism in a MASH mouse model","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118798","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118798"}}